TranScrip Partners, a U.K. CRO, has opened a Hong Kong office, TranScrip Partners Hong Kong. The new branch will be led by James Thorburn, who has over 25 years’ experience in clinical R&D involving drugs and medical devices, as well as a successful record of establishing CROs both in the U.K. and his native Hong Kong.

The company recently established an office in the U.S., and said further expansion into the APAC region is an important milestone in establishing its global presence. It follows the opening of offices in Australia in September 2012.